A protocol for a randomized controlled trial investigating the safety and cost-effectiveness of outpatient total hip arthroplasty

BMC Musculoskeletal Disorders

Brent A. Lanting¹  Bryn O. Zomar²  Jacquelyn D. Marsh²  Dianne M. Bryant² 

[1] Bone and Joint Institute, University of Western Ontario, London, ON, Canada;London Health Sciences Centre, London, ON, Canada;Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada;Faculty of Health Sciences, University of Western Ontario, London, ON, Canada;Bone and Joint Institute, University of Western Ontario, London, ON, Canada;

关键词: Outpatient;    Total hip arthroplasty;    Same day discharge;    Zelen;    Cost-effect;    Health economics;    Safety;    Cost;   

DOI  :  10.1186/s12891-020-03699-z

来源: Springer

【 摘 要 】

BackgroundA significant proportion of the overall cost of total hip arthroplasty (THA) results from the inpatient hospital stay following the procedure. Considering the substantial and increasing number of these procedures performed annually, shifting to an outpatient model of care where the patient is discharged home the same day as their surgery represents a potential for significant cost savings. The potential significant impact of an outpatient care model on constrained healthcare budgets and lack of high-quality evidence regarding its effectiveness warrants a rigorous comparative trial. The purpose of this prospective, randomized controlled trial is to evaluate outpatient care pathways for THA. Specifically, our objectives are to compare the rate of serious adverse events and estimate the cost-effectiveness of outpatient compared to standard inpatient THA.MethodsWe will include patients undergoing primary THA whom have an American Society of Anaesthetists status equal to or less than three, live within a 60-min driving distance of the institution and have an adult to accompany them home postoperatively and stay with them overnight. Consenting patients will be randomized to be discharged on the same day as surgery, as outpatients, or as inpatients according to standard of care (minimum of one night in hospital) using a modified Zelen consent model. The primary outcome measure is the incidence of serious adverse events at 30 days postoperative. Participants and their caregivers will complete secondary outcomes measures at each follow-up visit including patient-reported outcome measures and self-reported cost questionnaires.DiscussionThis protocol is the first randomized trial to use blinding to evaluate outpatient THA compared to standard overnight stay and first to prospectively perform a full economic evaluation. It is also the first adequately powered trial to prospectively assess the safety of outpatient THA. Successful completion of this study could have the potential to provide clinical evidence for the role of outpatient THA in current practice.Trial registrationThis study was retrospectively registered on ClinicalTrials.gov (NCT03026764) on March 9th, 2016.

【 授权许可】

CC BY